Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Chan

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Vaccine|December 14, 2011
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of ageJoost N Vermeulen, Joep M A Lange, Stephen K Tyring, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2012
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudyK E Schmader, M N Oxman, M J Levin, et al.
Vaccine|October 20, 2006
Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of ageClemente Diaz, Pietro Dentico, Rocio Gonzalez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2013
Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medicationsMichael R Irwin, Myron J Levin, Mark L Laudenslager, et al.
Nature Genetics|December 22, 2005
Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infectionVera S F Chan, Kelvin Y K Chan, Yongxiong Chen, et al.
Plos Pathogens|February 6, 2013
Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cellsYongxiong Chen, Shiuh-Lin Hwang, Vera S F Chan, et al.
Vaccine|July 20, 2002
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy childrenYu-Lung Lau, S J Rupert Vessey, Ivan S F Chan, et al.
Cell Reports|August 2, 2024
Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathyJordan S F Chan, Seyed Amirhossein Tabatabaei Dakhili, Maria Areli Lorenzana-Carrillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2014
Long-term persistence of zoster vaccine efficacyVicki A Morrison, Gary R Johnson, Kenneth E Schmader, et al.
Lancet (London, England)|June 2, 2018
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trialDrew J Winston, Kathleen M Mullane, Oliver A Cornely, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Vaccine|December 14, 2011
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of ageJoost N Vermeulen, Joep M A Lange, Stephen K Tyring, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2012
Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudyK E Schmader, M N Oxman, M J Levin, et al.
Vaccine|October 20, 2006
Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects > or =13 years of ageClemente Diaz, Pietro Dentico, Rocio Gonzalez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2013
Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medicationsMichael R Irwin, Myron J Levin, Mark L Laudenslager, et al.
Nature Genetics|December 22, 2005
Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infectionVera S F Chan, Kelvin Y K Chan, Yongxiong Chen, et al.
Plos Pathogens|February 6, 2013
Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cellsYongxiong Chen, Shiuh-Lin Hwang, Vera S F Chan, et al.
Vaccine|July 20, 2002
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy childrenYu-Lung Lau, S J Rupert Vessey, Ivan S F Chan, et al.
Cell Reports|August 2, 2024
Growth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathyJordan S F Chan, Seyed Amirhossein Tabatabaei Dakhili, Maria Areli Lorenzana-Carrillo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2014
Long-term persistence of zoster vaccine efficacyVicki A Morrison, Gary R Johnson, Kenneth E Schmader, et al.
Lancet (London, England)|June 2, 2018
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trialDrew J Winston, Kathleen M Mullane, Oliver A Cornely, et al.
Pageof 13